Evommune, Inc. Common Stock (EVMN)

CapEx to Revenue

5.01%

TTM · Retrieved:

EVMN logo

EVMN CapEx to Revenue

Current (TTM)5.01%
EVMN CapEx/Revenue (2.36% → 5.01%)
High-resolution chart · PNG

EVMN capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Evommune, Inc. Common Stock CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
1.8077%
1.2571%
2.36%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.